{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:04:31Z","timestamp":1761894271498},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,28]],"date-time":"2015-12-28T00:00:00Z","timestamp":1451260800000},"content-version":"vor","delay-in-days":3648,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2006]]},"DOI":"10.1111\/j.1469-0691.2006.01397.x","type":"journal-article","created":{"date-parts":[[2006,4,18]],"date-time":"2006-04-18T08:27:34Z","timestamp":1145348854000},"page":"55-66","source":"Crossref","is-referenced-by-count":18,"special_numbering":"S3","title":["Antibiotic consumption and generation of resistance in Streptococcus pneumoniae: the paradoxical impact of quinolones in a complex selective landscape"],"prefix":"10.1016","volume":"12","author":[{"given":"C.","family":"Garc\u00eda-Rey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.E.","family":"Mart\u00edn-Herrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Baquero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2006.01397.x_bib1","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1183\/09031936.01.17305580","article-title":"A thousand years of pulmonary medicine: good news and bad","volume":"17","author":"Murray","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib2","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3201\/eid0803.010192","article-title":"A European study on the relationship between antimicrobial use and antimicrobial resistance","volume":"8","author":"Bronzwaer","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib3","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)70799-6","article-title":"Outpatient antibiotic use in Europe and association with resistance: a cross\u2010national database study","volume":"365","author":"Goossens","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib4","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0140-6736(00)04972-2","article-title":"Variation in antibiotic use in the European Union","volume":"357","author":"Cars","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/jac\/dkh375","article-title":"Effect of social and climatological factors on antimicrobial use and Streptococcus pneumoniae resistance in different provinces in Spain","volume":"54","author":"Garcia\u2010Rey","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1128\/JCM.40.1.159-164.2002","article-title":"Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae","volume":"40","author":"Garcia\u2010Rey","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib7","first-page":"561","article-title":"Trends in antibiotic consumption in Spain, 1985\u20132000","volume":"118","author":"Lazaro Bengoa","year":"2002","journal-title":"Med Clin (Barc)"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib8","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/jac\/45.3.395","article-title":"Non\u2010hospital consumption of antibiotics in Spain 1987\u201397","volume":"45","author":"Bremon","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib9","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00228-003-0572-8","article-title":"Problems in collecting comparable national drug use data in Europe. the example of antibacterials","volume":"58","author":"Ronning","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib10","first-page":"132","article-title":"Antimicrobial consumption. Information sources and unity of measures","volume":"16","author":"Ruiz Bremon","year":"2003","journal-title":"Rev Esp Quimioter"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJM199708143370701","article-title":"The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance","volume":"337","author":"Seppala","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib12","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1093\/clinids\/21.6.1378","article-title":"Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci","volume":"21","author":"Seppala","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1089\/mdr.1997.3.117","article-title":"Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci","volume":"3","author":"Kristinsson","year":"1997","journal-title":"Microb Drug Resist"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM199907223410403","article-title":"Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network","volume":"341","author":"Chen","year":"1999","journal-title":"N Engl J Med"},{"issue":"Suppl. C","key":"10.1111\/j.1469-0691.2006.01397.x_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jac\/28.suppl_C.31","article-title":"A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe","volume":"28","author":"Baquero","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib16","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1073\/pnas.96.3.1152","article-title":"The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance","volume":"96","author":"Austin","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib17","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1128\/AAC.41.2.363","article-title":"The population dynamics of antimicrobial chemotherapy","volume":"41","author":"Lipsitch","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. 1","key":"10.1111\/j.1469-0691.2006.01397.x_bib18","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1093\/clinids\/24.Supplement_1.S9","article-title":"The population genetics of antibiotic resistance","volume":"24","author":"Levin","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib19","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1128\/AAC.38.1.122","article-title":"In vitro selective antibiotic concentrations of beta\u2010lactams for penicillin\u2010resistant Streptococcus pneumoniae populations","volume":"38","author":"Negri","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib20","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1097\/00006454-200012000-00011","article-title":"Frequency of penicillin\u2010resistant pneumococci in children is correlated to community utilization of antibiotics","volume":"19","author":"Melander","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib21","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s100960050337","article-title":"Influence of increased macrolide consumption on macrolide resistance of common respiratory pathogens","volume":"18","author":"Cizman","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib22","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jac\/47.4.475","article-title":"The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens","volume":"47","author":"Cizman","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib23","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/jac\/47.4.502","article-title":"Correlation between increased consumption of fluoroquinolones in outpatients and resistance of Escherichia coli from urinary tract infections","volume":"47","author":"Cizman","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/jac\/48.3.441","article-title":"Antibiotic use and resistance of Streptococcus pneumoniae in The Netherlands during the period","volume":"48","author":"De Neeling","year":"1994","journal-title":"J Antimicrob Chemother 2001"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/jac\/49.1.61","article-title":"Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany","volume":"49","author":"Reinert","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib26","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nm839","article-title":"Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States","volume":"9","author":"McCormick","year":"2003","journal-title":"Nat Med"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib27","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/clinids\/23.4.819","article-title":"Antibiotic resistance in Spain. what can be done? Task Force of the General Direction for Health Planning of the Spanish Ministry of Health","volume":"23","author":"Baquero","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 1","key":"10.1111\/j.1469-0691.2006.01397.x_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1179\/joc.1999.11.Supplement-2.35","article-title":"Evolving resistance patterns of Streptococcus pneumoniae: a link with long\u2010acting macrolide consumption?","volume":"11","author":"Baquero","year":"1999","journal-title":"J Chemother"},{"issue":"Suppl. 2","key":"10.1111\/j.1469-0691.2006.01397.x_bib29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/jac\/dkf504","article-title":"Antibiotic consumption and resistance selection in Streptococcus pneumoniae","volume":"50","author":"Baquero","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib30","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/IAI.73.1.298-307.2005","article-title":"Both innate immunity and type 1 humoral immunity to Streptococcus pneumoniae are mediated by MyD88 but differ in their relative levels of dependence on toll\u2010like receptor 2","volume":"73","author":"Khan","year":"2005","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.it.2003.12.006","article-title":"The innate immune response to pneumococcal lung infection: the untold story","volume":"25","author":"Kadioglu","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib32","doi-asserted-by":"crossref","first-page":"36426","DOI":"10.1074\/jbc.M403861200","article-title":"Nucleotide\u2010binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae","volume":"279","author":"Opitz","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib33","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1128\/AAC.43.1.178","article-title":"Antimicrobial resistance of 914 beta\u2010hemolytic streptococci isolated from pharyngeal swabs in Spain: results of a 1\u2010year (1996\u201397) multicenter surveillance study. The Spanish Surveillance Group for Respiratory Pathogens","volume":"43","author":"Baquero","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib34","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/AAC.43.2.357","article-title":"Antimicrobial resistance of 1113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: results of a 1\u2010year (1996\u201397) multicenter surveillance study. The Spanish Surveillance Group for Respiratory Pathogens","volume":"43","author":"Baquero","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib35","first-page":"265","article-title":"Antimicrobial susceptibility of 1422 Haemophilus influenzae isolates from respiratory tract infections in Spain. Results of a 1\u2010year (1996\u201397) multicenter surveillance study. Spanish Surveillance Group for Respiratory Pathogens","volume":"27","author":"Garcia\u2010Rodriguez","year":"1999","journal-title":"Infection"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib36","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1128\/AAC.45.12.3334-3340.2001","article-title":"Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1\u2010year (1998\u201399) multicenter surveillance study in Spain","volume":"45","author":"Perez\u2010Trallero","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib37","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1128\/AAC.45.11.3226-3228.2001","article-title":"Antimicrobial susceptibilities of 1730 Haemophilus influenzae respiratory tract isolates in Spain in 1998\u201399","volume":"45","author":"Marco","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib38","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1128\/AAC.49.5.1965-1972.2005","article-title":"Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain","volume":"49","author":"Perez\u2010Trallero","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib39","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1128\/AAC.45.10.2955-2957.2001","article-title":"Streptococcus pneumoniae isolates with reduced susceptibility to ciprofloxacin in Spain. clonal diversity and appearance of ciprofloxacin\u2010resistant epidemic clones","volume":"45","author":"Alou","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib40","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1128\/AAC.49.1.418-420.2005","article-title":"Streptococcus pyogenes pharyngeal isolates with reduced susceptibility to ciprofloxacin in Spain: mechanisms of resistance and clonal diversity","volume":"49","author":"Alberti","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib41","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1128\/JCM.41.6.2385-2390.2003","article-title":"Survey of emm gene sequences from pharyngeal Streptococcus pyogenes isolates collected in Spain and their relationship with erythromycin susceptibility","volume":"41","author":"Alberti","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib42","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1128\/JCM.43.3.1433-1436.2005","article-title":"Survey of emm\u2010like gene sequences from pharyngeal isolates of group C and group G streptococci collected in Spain","volume":"43","author":"Alberti","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib43","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1128\/AAC.47.11.3637-3639.2003","article-title":"Genetic relatedness of recently collected Spanish respiratory tract Streptococcus pneumoniae isolates with reduced susceptibility to amoxicillin","volume":"47","author":"Perez\u2010Trallero","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib44","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/jac\/46.5.767","article-title":"Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and beta\u2010lactam consumption in Spain (1979\u201397)","volume":"46","author":"Granizo","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib45","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/jac\/46.6.959","article-title":"Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain","volume":"46","author":"Granizo","year":"1986","journal-title":"J Antimicrob Chemother 2000"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib46","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.socscimed.2004.04.028","article-title":"Types of provincial structure and population health","volume":"60","author":"Young","year":"2005","journal-title":"Soc Sci Med"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib47","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1128\/JCM.40.8.2959-2963.2002","article-title":"Pharmacoepidemiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in Spain","volume":"40","author":"Garcia\u2010Rey","year":"2002","journal-title":"J Clin Microbiol"},{"issue":"Suppl. 2","key":"10.1111\/j.1469-0691.2006.01397.x_bib48","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1016\/S0399-077X(05)81383-6","article-title":"Relationship between antibiotic consumption and resistance in European hospitals","volume":"35","author":"Monnet","year":"2005","journal-title":"Med Mal Infect"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0924-8579(99)00135-1","article-title":"Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis","volume":"14","author":"Lopez\u2010Lozano","year":"2000","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl. 5","key":"10.1111\/j.1469-0691.2006.01397.x_bib50","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1469-0691.2001.00071.x","article-title":"Making sense of antimicrobial use and resistance surveillance data. application of ARIMA and transfer function models","volume":"7","author":"Monnet","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib51","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1086\/374221","article-title":"Relationship between spread of methicillin\u2010resistant Staphylococcus aureus and antimicrobial use in a French University hospital","volume":"36","author":"Muller","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib52","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/jac\/dkh282","article-title":"Relationship between ceftriaxone use and resistance to third\u2010generation cephalosporins among clinical strains of Enterobacter cloacae","volume":"54","author":"Muller","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib53","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3201\/eid1008.020694","article-title":"Antimicrobial drug use and methicillin\u2010resistant Staphylococcus aureus, Aberdeen, 1996\u20132000","volume":"10","author":"Monnet","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib54","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1128\/JCM.42.12.5571-5577.2004","article-title":"Trends in antimicrobial resistance in 1,968 invasive Streptococcus pneumoniae strains isolated in Spanish hospitals (2001\u201303): decreasing penicillin resistance in children's isolates","volume":"42","author":"Oteo","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib55","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1198-743X.2004.00979.x","article-title":"Increase of resistance to macrolides in invasive Streptococcus pneumoniae in Spain (2000\u201301)","volume":"10","author":"Oteo","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib56","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3201\/eid1104.040699","article-title":"Antimicrobial\u2010resistant invasive Escherichia coli","volume":"11","author":"Oteo","year":"2005","journal-title":"Spain Emerg Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib57","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1157\/13070401","article-title":"Etiology and antimicrobial susceptibility among uropathogens causing community\u2010acquired lower urinary tract infections: a nationwide surveillance study","volume":"23","author":"Andreu","year":"2005","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib58","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/jac\/dkf116","article-title":"Activity of six quinolones against 226 recent clinical isolates of Streptococcus pyogenes with reduced susceptibility to ciprofloxacin","volume":"50","author":"Latorre","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib59","series-title":"Anatomical Therapeutic Chemical (ATC) classification index with Defined Daily Doses (DDDs)","year":"2002"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib60","series-title":"ABC Calc \u2013 Antibiotic consumption calculator [Microsoft Excel application]","author":"Monnet","year":"2002"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib61","first-page":"265","article-title":"Consumo de quinolonas en el medio extrahospitalario en Espa\u00f1a. Bolet\u00edn Epidemiol\u00f3gico Semanal. Instituto Salud Carlos III","volume":"6","author":"Ruiz Tovar","year":"1998","journal-title":"Ministerio Sanidad y Consumo"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib62","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/jac\/dkf022","article-title":"Pharmacodynamic activity of fluoroquinolones against ciprofloxacin\u2010resistant Streptococcus pneumoniae","volume":"49","author":"Zhanel","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib63","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1128\/AAC.37.3.483","article-title":"Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis","volume":"37","author":"Drusano","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib64","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1128\/AAC.42.3.521","article-title":"Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy","volume":"42","author":"Thomas","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib65","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1099\/jmm.0.05178-0","article-title":"Fitness cost of fluoroquinolone resistance in Salmonella enterica serovar Typhimurium","volume":"52","author":"Giraud","year":"2003","journal-title":"J Med Microbiol"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib66","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/jac\/dkh505","article-title":"Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa","volume":"55","author":"Kugelberg","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib67","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1128\/AAC.49.6.2343-2351.2005","article-title":"Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections","volume":"49","author":"Komp Lindgren","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. A","key":"10.1111\/j.1469-0691.2006.01397.x_bib68","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jac\/38.suppl_A.117","article-title":"Trends in antibiotic resistance of respiratory pathogens: an analysis and commentary on a collaborative surveillance study","volume":"38","author":"Baquero","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib69","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/107662902760326896","article-title":"Clonal spread of resistant pneumococci despite diminished antimicrobial use","volume":"8","author":"Arason","year":"2002","journal-title":"Microb Drug Resist"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib70","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1128\/AAC.44.12.3481-3482.2000","article-title":"Influences of different factors on prevalence of ciprofloxacin resistance in Streptococcus pneumoniae in Spain","volume":"44","author":"Garcia\u2010Rey","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01397.x_bib71","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/jac\/dkh109","article-title":"Spectrum of antibiotic resistance of the Spain14\u20135 Streptococcus pneumoniae clone over a 22 year period","volume":"53","author":"Perez\u2010Trallero","year":"2004","journal-title":"J Antimicrob Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14613227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14613227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T01:48:41Z","timestamp":1555552121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14613227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":71,"alternative-id":["S1198743X14613227"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2006.01397.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2006]]}}}